Chattopadhyay Sanat's Insider Trades & SAST Disclosures
Chattopadhyay Sanat's most recent trade in Merck & Co Inc was a trade of 35,465 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 29, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Chattopadhyay Sanat.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 35,465 | 35,465 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 7,791 | 7,791 | - | - | Restricted Stock Unit | |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 235 | 823 | - | - | Common Stock Units | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 97.94 per share. | 27 Jan 2025 | 28,136 | 78,758 (0%) | 0% | 97.9 | 2,755,640 | Common Stock |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 2,050 | 4,262 | - | - | Restricted Stock Units | |
| Ashland Inc | Chattopadhyay Sanat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 175 | 583 | - | - | Common Stock Units | |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 144 | 406 | - | - | Common Stock Units | |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 132 | 261 | - | - | Common Stock Units | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 38,672 | 38,672 | - | - | Stock Option (Right to Buy) | |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 128 | 128 | - | - | Common Stock Units | |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 1,897 | 2,173 | - | - | Restricted Stock Units | |
| Merck & Co Inc | Chattopadhyay Sanat | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 119.43 per share. | 22 Jan 2024 | 26,716 | 26,716 (0%) | 0% | 119.4 | 3,190,692 | Common Stock |
| Ashland Inc | Sanat Chattopadhyay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2023 | 275 | 275 | - | - | Restricted Stock Units | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 45,643 | 45,643 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 115.07 per share. | 13 Apr 2023 | 67,892 | 0 (0%) | 0% | 115.1 | 7,812,366 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 67,892 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.04 per share. | 13 Apr 2023 | 67,892 | 67,892 (0%) | 0% | 56.0 | 3,804,668 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 66,163 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 115.06 per share. | 13 Apr 2023 | 66,163 | 67,892 (0%) | 0% | 115.1 | 7,612,702 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 13 Apr 2023 | 66,163 | 134,055 (0%) | 0% | 62.1 | 4,106,737 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 109.88 per share. | 23 Jan 2023 | 17,495 | 46,995 (0%) | 0% | 109.9 | 1,922,351 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2023 | 83,994 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.06 per share. | 09 Jan 2023 | 83,994 | 113,494 (0%) | 0% | 53.1 | 4,456,722 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 113.78 per share. | 09 Jan 2023 | 38,216 | 31,202 (0%) | 0% | 113.8 | 4,348,033 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 110.61 per share. | 09 Jan 2023 | 35,598 | 77,896 (0%) | 0% | 110.6 | 3,937,659 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 111.73 per share. | 09 Jan 2023 | 4,538 | 73,358 (0%) | 0% | 111.7 | 507,048 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 112.78 per share. | 09 Jan 2023 | 3,940 | 69,418 (0%) | 0% | 112.8 | 444,362 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 114.46 per share. | 09 Jan 2023 | 1,702 | 29,500 (0%) | 0% | 114.5 | 194,813 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 100.10 per share. | 28 Oct 2022 | 100,292 | 45,608 (0%) | 0% | 100.1 | 10,039,380 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,055 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 51,055 | 145,900 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 34,024 | 94,845 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 34,024 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,213 | 60,821 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 15,213 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 58,252 | 58,252 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 73.51 per share. | 24 Feb 2022 | 19,836 | 112,981 (0%) | 0% | 73.5 | 1,458,144 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 87.32 per share. | 29 Oct 2021 | 24,619 | 93,145 (0%) | 0% | 87.3 | 2,149,731 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 24,619 | 15,213 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 24,619 | 117,764 (0%) | 0% | 0 | Common Stock | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 85,714 | 85,714 | - | - | Stock Option (Right to Buy) | |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Grant, award, or other acquisition of securities at price $ 72.62 per share. | 26 Feb 2021 | 25,772 | 93,145 (0%) | 0% | 72.6 | 1,871,563 | Common Stock |
| Merck & Co Inc | Sanat Chattopadhyay | Exe V-P & Pres. MMD | Sale of securities on an exchange or to another person at price $ 83.01 per share. | 13 Aug 2020 | 10,380 | 67,373 (0%) | 0% | 83.0 | 861,676 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges